21 Results for "

OVCAR8

" in MedChemExpress (MCE) Product Catalog:
Products (21)

21 Results for "OVCAR8" in MCE Product Catalog:

10
10 Publications Verification
Cat. No.: HY-13065
CAS No.: 20784-50-3
Purity:  99.01%
Synonyms: Corylifolinin; Isobacachalcone
Isobavachalcone (Corylifolinin) is derived from Psoralea corylifolia Linn. and is a potent inhibitor of Akt signaling pathway, which induces apoptosis in human cancer cells (Inhibits OVCAR-8 cell growth with an IC50 value of 7.92 μM). Isobavachalcone also induces Reactive Oxyen Species (ROS) generation in OVCAR-8 cells and has exhibit cancer anti-promotive and anti-proliferative activity .
loading...
    loading...
4
4 Cited Publications
Cat. No.: HY-13237
CAS No.: 1285515-21-0
Purity:  99.82%
Target:  

LRRK2 Autophagy Mitophagy

Research Areas:  

Neurological Disease Cancer

GSK2578215A is a potent and highly selective LRRK2 inhibitor, which exhibits IC50s of around 10 nM against both wild-type LRRK2 and the G2019S mutant.
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-150231
CAS No.: 2376580-08-2
Purity:  99.77%
Target:  

YB-1

Research Areas:  

Cancer

SU056 is a YB-1 inhibitor. SU056 induces cell-cycle arrest, apoptosis, and inhibits cell migration in ovarian cancer cells. SU056 interacts with YB-1 and inhibits and its associated downstream proteins and pathways. SU056 can enhance the cytotoxic effects of Paclitaxel (HY-B0015) .
loading...
    loading...
Cat. No.: HY-131864
CAS No.: 2230821-38-0
Purity:  99.71%
Target:  

PROTACs EGFR

Research Areas:  

Cancer

SJF-1528 (PROTAC 1) is a potent EGFR PROTAC degrader with DC50 values of 39.2 nM and 736.2 nM for wild-type EGFR in OVCAR8 cells and Exon 20 Ins mutant EGFR in HeLa cells. SJF-1528 also degrades HER2. SJF-1528 promotes ubiquitination and degradation of EGFR and can be used in breast cancer research .
loading...
    loading...
Cat. No.: HY-133618
CAS No.: 2414418-49-6
Purity:  99.84%
Target:  

Wee1 PROTACs Apoptosis

Research Areas:  

Cancer

Pomalidomide-C3-adavosertib is a rapid and selective PROTAC Wee1 degrader (IC50=3.58 nM). Pomalidomide-C3-adavosertib shows anti-cancer cell proliferation activity, and induces apoptosis .
loading...
    loading...
Cat. No.: HY-131865
CAS No.: 2230821-40-4
Purity:  99.65%
Target:  

PROTACs EGFR

Research Areas:  

Infection Cancer

SJF-1521 is a selective EGFR PROTAC degrader. SJF-1521 is capable of inducing EGFR degradation in OVCAR8 cells. SJF-1521 can be used for tumor research .
loading...
    loading...
Cat. No.: HY-155874
CAS No.: 3034411-38-3
Purity:  99.91%
Target:  

CDK

Research Areas:  

Cancer

ZNL-05-044 is a CDK11 inhibitor with an IC50s of 0.23 μM and 0.27 μM against CDK11A and CDK11B, respectively (NanoBRET assay). ZNL-05-044 leads to G2/M cell cycle arrest and impairs RNA splicing .
loading...
    loading...
Cat. No.: HY-155218
CAS No.: 2488892-09-5
Target:  

PROTACs CDK

Research Areas:  

Cancer

TMX-2172 is a selective bivalent cereblon-recruiting PROTAC-based dual CDK2 and CDK5 degrader with IC50 values of 6.5 nM and 6.8 nM, respectively. TMX-2172 shows selectivity for CDK2 and CDK5 over other cell cycle CDKs (CDK1, CDK4, and CDK6) and transcriptional CDKs (CDK7 and CDK9). TMX-2172 inhibits CDK2/CDK5 enzymatic activity, induces their proteasomal degradation, reduces ASCL1 protein levels and half-life, induces cancer cell death, and exerts antiproliferative effects. TMX-2172 can be used for the research of ovarian cancer and small cell lung cancer .
loading...
    loading...
Cat. No.: HY-163743
CAS No.: 713112-69-7
Research Areas:  

Cancer

SIC-19 is a SIK2 inhibitor and promotes SIK2 protein degradation via the ubiquitination pathway. SIC-19 inhibits cancer cell growth and sensitizes cells to PARP inhibitors (Such as Olaparib (HY-10162)), as well as in ovarian cancer organoids and xenograft models .
loading...
    loading...
Cat. No.: HY-149431
Target:  

HSP Potassium Channel

Research Areas:  

Cancer

NDNA4 (compound 17) is a selective inhibitor of Hsp90α (IC50: 0.34 μM). NDNA4 is a permanently charged analog with low membrane permeability and low cytotoxicity against Ovcar-8 and MCF-10A ((IC50 >100 μM)). NDNA4 prevents disruption of hERG channel maturation without generating a heat shock response or causing degradation of Hsp90α-dependent client proteins .
loading...
    loading...
Cat. No.: HY-131864A
Purity:  98.90%
Target:  

PROTACs EGFR

Research Areas:  

Cancer

SJF-1528 (PROTAC 1) hemihydrate is a potent EGFR PROTAC degrader with DC50 values of 39.2 nM and 736.2 nM for wild-type EGFR in OVCAR8 cells and Exon 20 Ins mutant EGFR in HeLa cells. SJF-1528 hemihydrate also degrades HER2. SJF-1528 hemihydrate promotes ubiquitination and degradation of EGFR and can be used in breast cancer research .
loading...
    loading...
Cat. No.: HY-122650
CAS No.: 2130033-55-3
Purity:  98.43%
Target:  

Autophagy

Research Areas:  

Cancer

PHY34 is an inhibitor that inhibits ATP6V0A2 and CAS thereby inhibiting autophagy, and has a nanomolar effect. PHY34 inhibits cancer cell growth by inducing apoptosis and inhibits tumor growth in xenograft models. PHY34 can be used for research on high grade serous ovarian cancer .
loading...
    loading...
Cat. No.: HY-13065R
CAS No.: 20784-50-3
Synonyms: Corylifolinin (Standard); Isobacachalcone (Standard)
Isobavachalcone (Standard) is the analytical standard of Isobavachalcone. This product is intended for research and analytical applications. Isobavachalcone (Corylifolinin) is derived from Psoralea corylifolia Linn. and is a potent inhibitor of Akt signaling pathway, which induces apoptosis in human cancer cells (Inhibits OVCAR-8 cell growth with an IC50 value of 7.92 μM). Isobavachalcone also induces Reactive Oxyen Species (ROS) generation in OVCAR-8 cells and has exhibit cancer anti-promotive and anti-proliferative activity .
loading...
    loading...
Cat. No.: HY-149432
Target:  

HSP Potassium Channel

Research Areas:  

Cancer

NDNA3 (compound 14) is a selective inhibitor of Hsp90α (IC50: 0.51 μM). NDNA3 is a permanently charged analog with low membrane permeability and low toxicity to Ovcar-8 (IC50: 12.66 μM) and MCF-10A (IC50: 11.72 μM) cells. NDNA3 prevents disruption of hERG channel maturation without generating a heat shock response or causing degradation of Hsp90α-dependent client proteins .
loading...
    loading...
Cat. No.: HY-149388
CAS No.: 2954795-29-8
Target:  

Microtubule/Tubulin

Research Areas:  

Cancer

Anticancer agent 139 (Compound 6h) has potent anticancer activity. Anticancer agent 139 displayed a π–cationic interaction with the residue Lys352 of Tublin. Anticancer agent 139 has good anticancer activity against SNB-19, OVCAR-8, and NCI-H40 with PGIs of 86.61, 85.26, and 75.99, respectively. Anticancer agent 139 also has moderate anticancer activity against HOP-62, SNB-75, ACHN, NCI/ADR-RES, 786-O, A549/ATCC, HCT-116, and MDA-MB-231 with PGIs of 67.55, 65.46, 59.09, 59.02, 57.88, 56.88, 56.53, 56.4, and 51.88 respectively .
loading...
    loading...
Cat. No.: HY-P11011
CAS No.: 2232233-39-3
Synonyms: Pep R54; CXCR4 antagonist peptide 19
Target:  

CXCR ERK Akt

Research Areas:  

Cancer

Peptide R54 (Pep R54) is a CXCR4 antagonist. Peptide R54 inhibits CXCL12-dependent activation of pERK1/2 and pAKT. The combination of Peptide R54 and Nivolumab (HY-P9903) suppresses melanoma growth. Peptide R54 (acetate) is applicable to research related to melanoma and ovarian cancer .
loading...
    loading...
Cat. No.: HY-182052
CAS No.: 3063042-21-4
Synonyms: anti-NSCLC agent-2
Ferroptosis inducer-16 (anti-NSCLC agent-2) is a nitric oxide (NO) donor and a ferroptosis inducer. Ferroptosis inducer-16 inhibits DNA synthesis and colony formation. Ferroptosis inducer-16 disrupts lysosomal integrity by releasing NO, triggers iron overload and oxidative stress, downregulates the SLC7A11-GPX4 axis, depletes GSH, and accumulates lipid peroxides. Ferroptosis inducer-16 inhibits tumor growth in an OVCAR8/ADR xenograft mouse model without obvious toxicity, and can be used in the study of non-small cell lung cancer and drug-resistant ovarian cancer .
loading...
    loading...
Cat. No.: HY-164553
CAS No.: 2634811-35-9
Target:  

Apoptosis CDK

Research Areas:  

Cancer

ZSQ836 is an orally active dual covalent inhibitor of CDK12/CDK13, with an EC50 value of 32 nM against CDK12. ZSQ836 can induce apoptosis and exhibit anticancer activity in vivo. ZSQ836 can be used in the study of ovarian cancer .
loading...
    loading...
Cat. No.: HY-158076
Target:  

IAP

Research Areas:  

Cancer

S2/IAPinh is a conjugate, which consist of an inhibitor for the apoptosis protein inhibitor (IAPinh) and a ligand for sigma 2 SW43. S2/IAPinh exhibits an anti-proliferative and apoptotic-inducing effect through degradation of the cellular inhibitor for apoptosis protein (clAP-1) .
loading...
    loading...
Cat. No.: HY-P11011A
Synonyms: Pep R54 acetate; CXCR4 antagonist peptide 19 acetate
Target:  

CXCR ERK Akt

Research Areas:  

Cancer

Peptide R54 acetate (Pep R54 acetate) is a CXCR4 antagonist. Peptide R54 acetate inhibits CXCL12-dependent activation of pERK1/2 and pAKT. The combination of Peptide R54 acetate and Nivolumab (HY-P9903) suppresses melanoma growth. Peptide R54 (acetate) is applicable to research related to melanoma and ovarian cancer .
loading...
    loading...